Jincheng Wang, Kaili Hu, Xuanyan Cai, Bo Yang, Qiaojun He, Jiajia Wang, & Qinjie Weng. (2022). Targeting PI3K/AKT signaling for treatment of idiopathic pulmonary fibrosis. Elsevier.
Cita Chicago Style (17a ed.)Jincheng Wang, Kaili Hu, Xuanyan Cai, Bo Yang, Qiaojun He, Jiajia Wang, y Qinjie Weng. Targeting PI3K/AKT Signaling for Treatment of Idiopathic Pulmonary Fibrosis. Elsevier, 2022.
Cita MLA (9a ed.)Jincheng Wang, et al. Targeting PI3K/AKT Signaling for Treatment of Idiopathic Pulmonary Fibrosis. Elsevier, 2022.
Precaución: Estas citas no son 100% exactas.